Investing.com - Santhera Pharmaceuticals Holding reported on Thursday third quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Santhera Pharmaceuticals Holding announced earnings per share of CHF-0.20 on revenue of CHF1.7M. Analysts polled by Investing.com anticipated EPS of CHF-0.20 on revenue of CHF1.7M.
Santhera Pharmaceuticals Holding shares are down 41.35% from the beginning of the year, still down 54.12% from its 52 week high of CHF1.70 set on January 17.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar